BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6258925)

  • 21. Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells.
    Dave VP; Allan JE; Slobod KS; Smith FS; Ryan KW; Takimoto T; Power UF; Portner A; Hurwitz JL
    Virology; 1994 Mar; 199(2):376-83. PubMed ID: 7510085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein.
    Dallocchio F; Tomasi M; Bellini T
    Biochem Biophys Res Commun; 1994 Jun; 201(2):988-93. PubMed ID: 8003040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of fusion activity of ultraviolet light-inactivated Sendai virus in formation of target antigens recognized by cytotoxic T cells.
    Sugamura K; Shimizu K; Bach FH
    J Exp Med; 1978 Jul; 148(1):276-87. PubMed ID: 78960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of vesicular stomatitis virus major glycoprotein in determining the specificity of virus-specific and H-2-restricted cytolytic T cells.
    Sethi KK; Brandis H
    Eur J Immunol; 1980 Apr; 10(4):268-72. PubMed ID: 6249612
    [No Abstract]   [Full Text] [Related]  

  • 25. Ir gene control of the cytotoxic T lymphocyte response to Sendai virus: H-2k mice are low responders to Sendai.
    Shapiro ME; Burakoff SJ; Benacerraf B; Finberg RW
    J Immunol; 1981 Dec; 127(6):2571-4. PubMed ID: 6271873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mice lacking CD8+ T cells develop greater numbers of IgA-producing cells in response to a respiratory virus infection.
    Hyland L; Hou S; Coleclough C; Takimoto T; Doherty PC
    Virology; 1994 Oct; 204(1):234-41. PubMed ID: 8091654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Searching for MHC-restricted anti-viral antibodies: antibodies recognizing the nucleoprotein of influenza virus dominate the serological response of C57BL/6 mice to syngeneic influenza-infected cells.
    Tamminen WL; Wraith D; Barber BH
    Eur J Immunol; 1987 Jul; 17(7):999-1006. PubMed ID: 3497045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fusion of Sendai virus with the target cell membrane is required for T cell cytotoxicity.
    Gething M; Koszinowski U; Waterfield M
    Nature; 1978 Aug; 274(5672):689-91. PubMed ID: 209339
    [No Abstract]   [Full Text] [Related]  

  • 29. Elevated expression of the human parainfluenza virus type 1 F gene downregulates HN expression.
    Bousse T; Takimoto T; Murti KG; Portner A
    Virology; 1997 May; 232(1):44-52. PubMed ID: 9185587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elicitation and specificity of anti-vesicular stomatitis virus-specific cytotoxic T lymphocytes.
    Ruebush MJ; Hale AH; Lefrancois L; Harris DT; Burgess DE
    J Immunol; 1981 May; 126(5):2053-9. PubMed ID: 6260862
    [No Abstract]   [Full Text] [Related]  

  • 31. Neutralizing activity of the antibodies against two kinds of envelope glycoproteins of Sendai virus.
    Tozawa H; Komatsu H; Ohkata K; Nakajima T; Watanabe M; Tanaka Y; Arifuku M
    Arch Virol; 1986; 91(1-2):145-61. PubMed ID: 2428330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell surface glycoproteins of cytotoxic T lymphocytes induced in vivo and in vitro.
    Kaufmann Y; Berke G
    J Immunol; 1981 Apr; 126(4):1443-6. PubMed ID: 6451646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin.
    Wabuke-Bunoti MA; Taku A; Fan DP; Kent S; Webster RG
    J Immunol; 1984 Oct; 133(4):2194-201. PubMed ID: 6206156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sendai virus glycoproteins are T cell-dependent B cell mitogens.
    Kizaka S; Goodman-Snitkoff G; McSharry JJ
    Infect Immun; 1983 May; 40(2):592-600. PubMed ID: 6302000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. H-2-linked murine cytotoxic T cell responses specific for sendai virus-infected cells.
    Kurrle R; Röllinghoff M; Wagner H
    Eur J Immunol; 1978 Dec; 8(12):910-2. PubMed ID: 83237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms for generating cell membrane antigens that are recognized by cytotoxic T lymphocytes.
    Ciavarra R; Kang CY; Forman J
    Fed Proc; 1981 Feb; 40(2):222-7. PubMed ID: 6257559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The induction of virus-specific cytotoxic T lymphocytes with solubilized viral and membrane proteins.
    Finberg R; Mescher M; Burakoff SJ
    J Exp Med; 1978 Dec; 148(6):1620-7. PubMed ID: 214512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of sendai virus fusion-glycoprotein in target cell susceptibility to cytotoxic T cells.
    Sugamura K; Shimizu K; Zarling DA; Bach FH
    Nature; 1977 Nov; 270(5634):251-3. PubMed ID: 304180
    [No Abstract]   [Full Text] [Related]  

  • 39. Recognition of viral glycoproteins by influenza A-specific cross-reactive cytolytic T lymphocytes.
    Koszinowski UH; Allen H; Gething MJ; Waterfield MD; Klenk HD
    J Exp Med; 1980 Apr; 151(4):945-58. PubMed ID: 6154763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difference in capacity of Sendai virus envelope components to induce cytotoxic T lymphocytes in primary and secondary immune responses.
    Fukami Y; Hosaka Y; Yasuda Y; Bonilla JA
    Infect Immun; 1979 Dec; 26(3):815-21. PubMed ID: 231009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.